BioHealth News Archive
Human genome drugs: Where are the miracle cures from genomics? Did the genome map make us healthier?
Sequencing the human genome seemed like a discovery so important that it couldn’t be overhyped—we had, after all, transcribed the blueprint for human life—but…
Read More
Capital Buzz: Revolution begins new fund with $50M to spare – The Washington Post
An early-stage investment fund founded by Revolution has raised $200 million in commitments, blowing past its $150 million goal. The new fund, Revolution Ventures,…
Read More
Is your school underrated for tech entrepreneurship? – PandoDaily
At a time when many states are looking to their research universities as sources of innovation and entrepreneurship, it is great to see that…
Read More
Emergent to Buy Gaithersburg Office from COPT – Daily News Article – GlobeSt.com
Emergent Biosolutions, the maker of the only FDA-licensed anthrax vaccine, is expanding its footprint in Montgomery County, with a little bit of financial help…
Read More
Here’s a look at healthcare’s top 10 corporate investors and acquirers – MedCity News
These days, having a strategic investor or partner has become almost a matter of survival for healthcare startups. Corporate investing and partnering has really…
Read More
University of Maryland entrepreneurship program extends eligibility to all majors – The Diamondback : Campus
Anyone can have a great business idea, and now students don’t have to be enrolled in the business school to get help making their…
Read More
Getting Big Results from a Small Business Unit – Steven J. Thompson – Harvard Business Review
Earlier this year Sun Yat-sen University, a well-regarded institution in Guangzhou in the Guangdong province of China, announced that the university and affiliated hospitals…
Read More
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww? – Xconomy
Bureaucracy is one of the dirty words in business. Nobody wants to publicly admit their company is bogged down with too many layers of…
Read More
Gliknik Enters Into Licensing Agreement With Pfizer for Drug Candidate Targeting Autoimmune Diseases
GL-2045 is Gliknik’s Lead Recombinant Stradomer™ Designed to Improve on Pooled Human Intravenous Immunoglobulin Gliknik Inc., a privately held biopharmaceutical company, today announced that…
Read More
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww?
Bureaucracy is one of the dirty words in business. Nobody wants to publicly admit their company is bogged down with too many layers of…
Read More
Here’s a look at healthcare’s top 10 corporate investors and acquirers
These days, having a strategic investor or partner has become almost a matter of survival for healthcare startups. Corporate investing and partnering has really…
Read More
Northrop Grumman, bwtech@UMBC Graduate First Three Companies From Cyber Cync Program NYSE:NOC
Northrop Grumman Corporation (NYSE:NOC) and the University of Maryland, Baltimore County's Research Park Corporation - also known as bwtech@UMBC - hosted a ceremony today…
Read More
Baltimore-based Gliknik enters into licensing agreement with Pfizer
BALTIMORE, MARYLAND, September 30, 2013 – Gliknik Inc., a privately held biopharmaceutical company, today announced that it has entered into an exclusive worldwide licensing…
Read More
New Investment Fund Will Advance Late-Stage Vaccines and other Global Health Technologies
A new investment fund structured by JPMorgan Chase & Co. (NYSE:JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow…
Read More
Jumpstart Our Business Startups (JOBS) Act: Impact on the Biotechnology Industry | BIO
President Obama signed the Jumpstart Our Business Startups (JOBS) Act into law on April 5, 2012. BIO advocated strongly for this new law, which…
Read More